ARCHIVES

BRAF Mutation Testing Classifies Indeterminate FNA Samples

This article is from The Cancer Letter archive.

Vol. 36 No. 3 | March 29, 2013

Download PDF Visit The Full Archive

Related Articles

ACS Elects New Volunteer Leaders

November 19, 2010

NLST Shows 20.3 Percent Mortality Benefit For CT Vs. X-Ray In Lung Cancer Screening

November 5, 2010

NCI to Undergo More GAO Probes

July 15, 1977

Phase 1 Study Asked to Determine If Drug Administration Timing Improves Results

April 4, 1986

FDA Announces Plan to Reform Drug Approval, Hire Outside Experts To Handel Some Reviews

November 22, 1991

Cancer Control Reps Discuss Issues of ‘80s

October 17, 1980